Click the links below to view the Mesothelioma Lung Cancer Asbestos news article of your choice.
Mon, 02 Apr 2018 14:24:58 EDT
Investigators have found that combined treatment with two cancer immunotherapy drugs -- one a novel immune modulator and one that focuses and activates the anti-tumor immune response -- significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
Mon, 06 Nov 2017 13:20:18 EST
Researchers have shown for the first time in mice that long and thin nanomaterials called carbon nanotubes may have the same carcinogenic effect as asbestos: they can induce the formation of mesothelioma. The findings were observed in 10 percent -- 25 percent of the 32 animals included in the study, which has not yet been replicated in humans.
Thu, 02 Nov 2017 09:11:18 EDT
A landmark study into the health impacts of living in a house with loose-fill asbestos insulation.
Thu, 14 Sep 2017 15:23:47 EDT
Investigators have uncovered a new genetic cause of mesothelioma: a genetic rearrangement in the ALK gene, observed in three patients with peritoneal mesothelioma. Unlike previously known causes, this new discovery points to a potential therapeutic approach for those few patients whose tumors harbor the mutation.
Mon, 05 Jun 2017 11:00:54 EDT
Malignant pleural mesothelioma or MPM is a rare cancer, but its incidence has been rising. This cancer is usually associated with asbestos exposure, and patients have a median life expectancy of only 13-15 months. All patients relapse despite initial chemotherapy, more than 50% of them within six months after stopping treatment. There are currently no effective therapeutic options for patients with MPM.
Sun, 08 Oct 2017 09:00:00 PDT
Pneumoconiosis is a lung disease caused by dust particles. Symptoms include breathing difficulty and a cough. It can result from exposure to coal dust, asbestos particles, and cotton dust. It is considered an occupational risk. Complications include tuberculosis and respiratory failure. Employers may provide screening.
Fri, 15 Sep 2017 06:00:00 PDT
Mesothelioma is a rare and aggressive tumor that, in many cases, results from exposure to asbestos.
Fri, 31 Mar 2017 07:00:00 PDT
Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.
Tue, 25 Oct 2016 00:00:00 PDT
Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.
Menu